Holen Sie sich die Stockscreener-App
65.39
0.30%
-0.20
Handel nachbörslich:
65.41
0.02
+0.03%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$65.59
Offen:
$65.15
24-Stunden-Volumen:
1.05M
Relative Volume:
0.56
Marktkapitalisierung:
$31.61B
Einnahmen:
$10.63B
Nettoeinkommen (Verlust:
$819.00M
KGV:
39.45
EPS:
1.6577
Netto-Cashflow:
$1.59B
1W Leistung:
-1.37%
1M Leistung:
-11.19%
6M Leistung:
-11.80%
1J Leistung:
-13.05%
1-Tages-Spanne:
$65.06
$65.71
1-Wochen-Bereich:
$64.54
$66.28
52-Wochen-Spanne:
$61.84
$87.64
Alcon Inc Stock (ALC) Company Profile
Compare ALC vs ISRG, BDX, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
65.39 | 31.71B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
398.30 | 142.05B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
182.52 | 49.85B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.30 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.30 | 30.21B | 29.14B | 1.07B | 1.05B | 1.1956 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-30 | Eingeleitet | William Blair | Mkt Perform |
| 2026-01-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-09 | Herabstufung | Stifel | Buy → Hold |
| 2025-12-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon stock trades near its 52-week low - AD HOC NEWS
Alcon Inc. (ALC) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alcon stock falls 0.9 percent at the close on September 22 - AD HOC NEWS
Alcon stock falls 0.9 percent as shares stay below yearly high - AD HOC NEWS
Alcon stock heads into the open after a 0.26 percent fall - AD HOC NEWS
Alcon stock ends the day modestly lower at the close on the NYSE - AD HOC NEWS
Alcon stock gains as revenue and guidance stay in view - AD HOC NEWS
Alcon Inc. (ALC) Stock Analysis: Eyeing A 31% Upside Potential In The Healthcare Sector - DirectorsTalk Interviews
Alcon stock heads into the open after a 0.04 percent dip. - AD HOC NEWS
Price to sales forward of Alcon AG – HAN:2U3 - TradingView
Alcon stock holds steady as analysts reaffirm Buy ratings - AD HOC NEWS
Alcon Stock Price Forecast. Should You Buy ALC? - StockInvest.us
Alcon stock heads into the open after a 3.0 percent slide - AD HOC NEWS
Alcon Inc (1ALC) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Alcon stock dips as investors await next earnings signal - AD HOC NEWS
Alcon stock heads into the open after a 0.33 percent gain - AD HOC NEWS
Alcon CEO Says US Drug Pricing Deal May Limit European Products - bloomberg.com
Alcon warns that US proposal could cause companies to abandon Europe - medwatch.com
Alcon stock gains on Q2 2026 earnings beat and Berenberg Buy rating - ad-hoc-news.de
Alcon stock gains support from Berenberg Buy rating and solid Q2 2026 figures - ad-hoc-news.de
Wet Age-Related Macular Degeneration Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Opthea Limited, Regenxbio, Alkahest, Graybug Vision, Alcon Research - Barchart.com
Alcon, RxSight Form Collaboration to Develop Adjustable PCIOLs - Medical Product Outsourcing
Alcon stock gains as Berenberg reiterates Buy rating and 85-franc target - ad-hoc-news.de
Alcon stock heads into the open after a 2.5 percent drop - ad-hoc-news.de
Alcon stock heads into the open after a 1.97 percent drop - ad-hoc-news.de
RXST: Strategy centers on U.S. growth, deeper utilization, and Alcon partnership for long-term transformation - TradingView
RXST: U.S. growth, deeper LAL adoption, and Alcon partnership drive a disciplined transformation strategy - TradingView
Alcon stock eases but stays supported by recent H1 2026 growth - ad-hoc-news.de
Alcon stock dips as investors weigh product news and upcoming Q3 2026 earnings - ad-hoc-news.de
Alcon stock heads into the open after a modest September 7, 2026 decline - ad-hoc-news.de
Alcon stock edges lower as investors weigh recent performance and upcoming Q3 earnings - ad-hoc-news.de
Alcon Inc. (ALC) Stock Analysis: Exploring A Promising 20.91% Upside Potential - DirectorsTalk Interviews
Alcon stock heads into the open after a modest decline - ad-hoc-news.de
Alcon introduces UNITY M ophthalmic microscope - glance.eyesoneyecare.com
Alcon stock trades softer as options activity and Q2 growth shape investor view - ad-hoc-news.de
Alcon Market Sentiment - Benzinga España
Alcon stock eases after UNITY M launch and strong Q2 figures - AD HOC NEWS
The Back-to-School Essential Parents Are Overlooking: Eye Exams - Scripps News
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Deliveri - GuruFocus
Alcon stock dips in Zurich as UNITY M launch follows strong Q2 2026 figures - AD HOC NEWS
Alcon Announces Initial Launch of UNITY M Surgical Microscope in US, Japan - marketscreener.com
Alcon Debuts UNITY M Ophthalmic Surgical Microscope in U.S., Japan - Medical Product Outsourcing
Alcon: A Re-Rating In Eyesight - Seeking Alpha
Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control - News-Press NOW
Are Options Traders Betting on a Big Move in Alcon Stock? - TradingView
Changes in working capital of Alcon AG – BX:2U3 - TradingView
Alcon stock holds near 52 week high after Q2 beat - AD HOC NEWS
Alcon (SWX:ALC), What Is Behind The Fresh Attention? - Yahoo Finance
Alcon's Clareon Monofocal IOL Receives EUMDR Certification Through TÜV SÜD - Yahoo Finance
Alcon stock holds steady as drug pricing deal and Q2 reset shape outlook - AD HOC NEWS
Alcon stock edges higher as Q2 2026 impairment and earnings reset the outlook - AD HOC NEWS
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):